Wednesday, May 08, 2024 CCTG is honoured to recognize Dr. Hira Mian with the Ralph Meyer Phase III Program Young Investigator Award which is presented to a young investigator who worked on a Phase III trial and contributed significantly to the conduct the trial.“I am thrilled to receive this young investigator award which is really on behalf of all my colleagues both at McMaster, CCTG and throughout Canada. Thank you team and looking forward to the many years of collaboration.”Dr. Hira Mian is a hematologist at the Juravinski Cancer Centre and an assistant professor within the department of oncology at McMaster University in Hamilton, Ontario, where she leads the multiple myeloma program. Dr. Mian completed her clinical training at the University of Toronto and furthered her research training at McMaster University where she obtained her Master’s in Health Research Methodology and completed the Clinician Investigator Program.Dr. Mian’s research interests center around health services and outcomes and clinical trials, with a specific focus on the care of older adults with MM. She is the recipient of numerous grants and an early career award. She serves as a board member of Myeloma Canada and an investigator with the Canadian Myeloma Research Group (CMRG) and the Canadian Cancer Clinical Trials Group. She is the study chair for the phase III CCTG trial MY13.
